Precision BioSciences, Inc.

North America Legal Chronicle. June 30, 2022

Precision BioSciences’ Gene Editing Collaboration with Novartis

By Martina Bellini

Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan advised Precision BioSciences on the deal. Precision BioSciences (Nasdaq: DTIL), a clinical stage gene editing company based in Durham,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. June 24, 2022

Precision BioSciences’ $50 Million Common Stock Offering

By Laura Testa

Latham & Watkins represented Precision BioSciences, Inc. in the offering. Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Improving’s Acquisition of Leniolabs

Shuttle Pharmaceuticals’ $4.5 Million Common Stock Offering

Jüsto’s Partnership with Amazon

Companhia Jaguari de Energia’s R$300 Million Unsecured Debentures Issuance

Pampa Energía’s US$84 Million Notes Issuance

Vista’s US$150 Million Notes Issuance

Bright Software Group’s Acquisition Of Anglia Registrars (Inform Direct)

Infortar’s Acquisition of Tallinna Raamatutrükikoda

Brookfield’s $2.3 Billion Acquisition Of Minority Stakes In Four UK Offshore Wind Farms From Ørsted

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Kokshetau Hospital’s €365 Million PPP Financing

Fourth Milling Company’s Initial Public Offering on Tadawul

A101 Yeni Magazacilik A.S.’ $200 Million Sustainability Loan

Waaree Energies’ $515 Million IPO

Bureau Veritas’ Acquisition Of The APP Group From Five V Capital

Pilbara’s Revolving Credit Facility

High-Profile Employment Litigator Joins Polsinelli in D.C.

O’Melveny Welcomes Experienced Houston Energy Lawyer David Aaronson

Paul Hastings Enhances Premier Private Equity and M&A Platform with New York Finance Partner

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

High-Profile Employment Litigator Joins Polsinelli in D.C.

O’Melveny Welcomes Experienced Houston Energy Lawyer David Aaronson

Paul Hastings Enhances Premier Private Equity and M&A Platform with New York Finance Partner

Precision BioSciences’ Gene Editing Collaboration with Novartis

Standard 1 Year Membership Required

Precision BioSciences’ $50 Million Common Stock Offering

Standard 1 Year Membership Required